Lynparza significantly delayed disease progression as 1st-line maintenance treatment in germline BRCA-mutated metastatic pancreatic cancer Read more
Imbrium and TetraGenetics Announce Strategic Research Collaboration and License Option to Develop Novel Biologic Therapeutics for Pain Read more
Selexis SA and Turgut Expand Biosimilar Development Relationship by Signing Two Commercial License Agreements Read more
Co-Chairs Centrexion Therapeutics & Metys Pharmaceuticals invite to SMi’s 19th Annual Pain Therapeutics Read more
Conference Co-Chairs from MedImmune & Ferring Pharmaceuticals invites you to attend Pre-filled Syringes West Coast 2019 Read more
Amgen, Cytokinetics And Servier Announce Start Of METEORIC-HF, The Second Phase 3 Clinical Trial Of Omecamtiv Mecarbil In Patients With Heart Failure Read more
Urovant Sciences Enters into Flexible Agreement for up to $100 Million Debt Financing with Hercules Capital Read more
Novartis to pursue transformational therapy to reduce risk of cardiovascular disease in people living with elevated levels of inherited lipoprotein(a) Read more